1. ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2
   Qingyu Luo et al, 2018, Cancer Letters CrossRef
2. CRISPR/Cas9-Mediated Gene Knockout of ARID1A Promotes Primary Progesterone Resistance by Downregulating Progesterone Receptor B in Endometrial Cancer Cells
   Haizhen Wang et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
3. Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
   An Tong et al, 2023, Frontiers in Genetics CrossRef
4. Diagnostic significance and prognostic role of the ARID1A gene in cancer outcomes (Review)
   Evangelia Pavlidou et al, 2020, World Academy of Sciences Journal CrossRef
5. FSH receptor binding inhibitor up-regulates ARID1A and PTEN genes associated with ovarian cancers in mice
   Zhuandi Gong et al, 2019, Brazilian Journal of Medical and Biological Research CrossRef
6. Remodeling of the ARID1A tumor suppressor
   Qingyu Luo et al, 2020, Cancer Letters CrossRef
7. The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
   Ieva Vaicekauskaitė et al, 2022, International Journal of Molecular Sciences CrossRef
8. High‐level expression of ARID1A predicts a favourable outcome in triple‐negative breast cancer patients receiving paclitaxel‐based chemotherapy
   Yuan‐Feng Lin et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
9. ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer
   Yang-kai Jiang et al, 2023, Current Medical Science CrossRef
10. Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy
    Yang Li et al, 2023, Cancer Cell International CrossRef
11. A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer
    Xun Tian et al, 2021, Advanced Science CrossRef
12. Fibroblast Growth Factor 11 (FGF11) Promotes Progression and Cisplatin Resistance Through the HIF-1α/FGF11 Signaling Axis in Ovarian Clear Cell Carcinoma
    Min Yin et al, 2023, Cancer Management and Research CrossRef